The IMCore of the UW Sensory Biology Center is pleased to announce the availability of an Illumina NextSeq 1000 sequencer. This equipment is purchased exclusively via an administrative supplement ...
BIOS/UEFI vulnerabilities in the iSeq 100 DNA sequencer from U.S. biotechnology company Illumina could let attackers disable devices used for detecting illnesses and developing vaccines.
Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback